{"entity":{"type":"insider","cik":"0001308598","url":"/insider/0001308598","json_url":"/insider/0001308598.json","name":"Swieca Henry","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":9,"first":"2007-02-20","last":"2007-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Swieca Henry","source":"filing","n_filings":9,"first_seen":"2007-02-20","last_seen":"2007-08-15"}],"transactions":[{"id":7683568,"accession":"0000902664-07-002650","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000902664-07-002650","line_url":"/filing/0000902664-07-002650#line-6","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Highbridge Convertible Arbitrage Master Fund, L.P.; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shares of common stock, $0.01 par (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2343.0,"shares_display":"2,343","price_per_share":6.46,"price_display":"6.46","price_state":"stated","total_value":15135.78,"total_display":"15,135.78","shares_owned_after":2343.0,"shares_owned_after_display":"2,343","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-13","filed_date":"2007-08-15","scope":"insider"},{"id":7683566,"accession":"0000902664-07-002650","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000902664-07-002650","line_url":"/filing/0000902664-07-002650#line-5","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Highbridge Convertible Arbitrage Master Fund, L.P.; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":326000.0,"total_display":"326,000.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-13","filed_date":"2007-08-15","scope":"insider"},{"id":7683563,"accession":"0000902664-07-002650","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-07-002650","line_url":"/filing/0000902664-07-002650#line-4","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Highbridge Convertible Arbitrage Master Fund, L.P.; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":6.49,"price_display":"6.49","price_state":"stated","total_value":324500.0,"total_display":"324,500.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-13","filed_date":"2007-08-15","scope":"insider"},{"id":7255212,"accession":"0000902664-07-002431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-07-002431","line_url":"/filing/0000902664-07-002431#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; Highbridge Convertible Arbitrage Master Fund, L.P.; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Highbridge International LLC; Dubin Glenn","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shares of common stock, $0.01 par (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":7.21,"price_display":"7.21","price_state":"stated","total_value":432600.0,"total_display":"432,600.00","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-02","filed_date":"2007-08-06","scope":"insider"},{"id":7683554,"accession":"0000902664-07-002341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-07-002341","line_url":"/filing/0000902664-07-002341#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge Convertible Arbitrage Master Fund, L.P.; Highbridge International LLC; Dubin Glenn; Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shrs. of common stock $0.01 par val. per shr. (Common Stock)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":7.71,"price_display":"7.71","price_state":"stated","total_value":424050.0,"total_display":"424,050.00","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-07-24","filed_date":"2007-07-26","scope":"insider"},{"id":7335726,"accession":"0000902664-07-002298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-07-002298","line_url":"/filing/0000902664-07-002298#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shares of common stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22192.0,"shares_display":"22,192","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":171988.0,"total_display":"171,988.00","shares_owned_after":22192.0,"shares_owned_after_display":"22,192","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-07-16","filed_date":"2007-07-18","scope":"insider"},{"id":7941049,"accession":"0000902664-07-002279","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-07-002279","line_url":"/filing/0000902664-07-002279#line-4","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Highbridge International LLC; Highbridge Convertible Arbitrage Master Fund, L.P.; Dubin Glenn","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.71,"price_display":"7.71","price_state":"stated","total_value":3855.0,"total_display":"3,855.00","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-07-12","filed_date":"2007-07-13","scope":"insider"},{"id":7941045,"accession":"0000902664-07-002279","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-07-002279","line_url":"/filing/0000902664-07-002279#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Highbridge International LLC; Highbridge Convertible Arbitrage Master Fund, L.P.; Dubin Glenn","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shares of common stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54013.0,"shares_display":"54,013","price_per_share":7.73,"price_display":"7.73","price_state":"stated","total_value":417520.49,"total_display":"417,520.49","shares_owned_after":54013.0,"shares_owned_after_display":"54,013","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-07-11","filed_date":"2007-07-13","scope":"insider"},{"id":7010340,"accession":"0000902664-07-001453","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-14","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3300.0,"shares_display":"3,300","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":27225.0,"total_display":"27,225.00","shares_owned_after":6090.0,"shares_owned_after_display":"6,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-11","filed_date":"2007-04-12","scope":"insider"},{"id":7010339,"accession":"0000902664-07-001453","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-13","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2710.0,"shares_display":"2,710","price_per_share":8.28,"price_display":"8.28","price_state":"stated","total_value":22438.8,"total_display":"22,438.80","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-11","filed_date":"2007-04-12","scope":"insider"},{"id":7010337,"accession":"0000902664-07-001453","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-12","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2390.0,"shares_display":"2,390","price_per_share":8.23,"price_display":"8.23","price_state":"stated","total_value":19669.7,"total_display":"19,669.70","shares_owned_after":2790.0,"shares_owned_after_display":"2,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-11","filed_date":"2007-04-12","scope":"insider"},{"id":7010335,"accession":"0000902664-07-001453","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-11","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":8.27,"price_display":"8.27","price_state":"stated","total_value":5789.0,"total_display":"5,789.00","shares_owned_after":7290.0,"shares_owned_after_display":"7,290","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-11","filed_date":"2007-04-12","scope":"insider"},{"id":7010333,"accession":"0000902664-07-001453","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-10","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.26,"price_display":"8.26","price_state":"stated","total_value":4130.0,"total_display":"4,130.00","shares_owned_after":6590.0,"shares_owned_after_display":"6,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-11","filed_date":"2007-04-12","scope":"insider"},{"id":7010331,"accession":"0000902664-07-001453","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-9","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":3288.0,"total_display":"3,288.00","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-11","filed_date":"2007-04-12","scope":"insider"},{"id":7010318,"accession":"0000902664-07-001453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-07-001453","line_url":"/filing/0000902664-07-001453#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shs of com stock, $0.01 par value p/share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10253.0,"shares_display":"10,253","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":84587.25,"total_display":"84,587.25","shares_owned_after":10253.0,"shares_owned_after_display":"10,253","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-10","filed_date":"2007-04-12","scope":"insider"},{"id":6783816,"accession":"0000902664-07-001439","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-07-001439","line_url":"/filing/0000902664-07-001439#line-4","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shs of com stock, $0.01 par value p/share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11300.0,"shares_display":"11,300","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":92660.0,"total_display":"92,660.00","shares_owned_after":11300.0,"shares_owned_after_display":"11,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-09","filed_date":"2007-04-11","scope":"insider"},{"id":6783813,"accession":"0000902664-07-001439","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-07-001439","line_url":"/filing/0000902664-07-001439#line-3","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Swieca Henry; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34000.0,"shares_display":"34,000","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":280500.0,"total_display":"280,500.00","shares_owned_after":45300.0,"shares_owned_after_display":"45,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-09","filed_date":"2007-04-11","scope":"insider"},{"id":8184419,"accession":"0000902664-07-001165","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000902664-07-001165","line_url":"/filing/0000902664-07-001165#line-10","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Dubin Glenn; HIGHBRIDGE CAPITAL CORP; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shares of common stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":8.19,"price_display":"8.19","price_state":"stated","total_value":5733.0,"total_display":"5,733.00","shares_owned_after":700.0,"shares_owned_after_display":"700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-02","filed_date":"2007-03-06","scope":"insider"},{"id":8184414,"accession":"0000902664-07-001165","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000902664-07-001165","line_url":"/filing/0000902664-07-001165#line-9","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Dubin Glenn; HIGHBRIDGE CAPITAL CORP; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":330000.0,"total_display":"330,000.00","shares_owned_after":81552.0,"shares_owned_after_display":"81,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-02","filed_date":"2007-03-06","scope":"insider"},{"id":8184410,"accession":"0000902664-07-001165","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000902664-07-001165","line_url":"/filing/0000902664-07-001165#line-8","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Dubin Glenn; HIGHBRIDGE CAPITAL CORP; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":8.23,"price_display":"8.23","price_state":"stated","total_value":329200.0,"total_display":"329,200.00","shares_owned_after":41552.0,"shares_owned_after_display":"41,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-02","filed_date":"2007-03-06","scope":"insider"},{"id":8184404,"accession":"0000902664-07-001165","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000902664-07-001165","line_url":"/filing/0000902664-07-001165#line-7","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Dubin Glenn; HIGHBRIDGE CAPITAL CORP; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":8.26,"price_display":"8.26","price_state":"stated","total_value":247800.0,"total_display":"247,800.00","shares_owned_after":111552.0,"shares_owned_after_display":"111,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-02","filed_date":"2007-03-06","scope":"insider"},{"id":8184396,"accession":"0000902664-07-001165","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000902664-07-001165","line_url":"/filing/0000902664-07-001165#line-6","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HIGHBRIDGE CAPITAL MANAGEMENT LLC; Swieca Henry; Dubin Glenn; HIGHBRIDGE CAPITAL CORP; Highbridge International LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":852.0,"shares_display":"852","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":6986.4,"total_display":"6,986.40","shares_owned_after":1552.0,"shares_owned_after_display":"1,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-02","filed_date":"2007-03-06","scope":"insider"},{"id":8538341,"accession":"0000902664-07-001053","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000902664-07-001053","line_url":"/filing/0000902664-07-001053#line-12","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL CORP; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Shares of common stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":8.67,"price_display":"8.67","price_state":"stated","total_value":260100.0,"total_display":"260,100.00","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":8538340,"accession":"0000902664-07-001053","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000902664-07-001053","line_url":"/filing/0000902664-07-001053#line-11","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL CORP; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9065.0,"shares_display":"9,065","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":79137.45,"total_display":"79,137.45","shares_owned_after":56176.0,"shares_owned_after_display":"56,176","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":8538339,"accession":"0000902664-07-001053","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000902664-07-001053","line_url":"/filing/0000902664-07-001053#line-10","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL CORP; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8743.0,"shares_display":"8,743","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":76413.82,"total_display":"76,413.82","shares_owned_after":47111.0,"shares_owned_after_display":"47,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":8538338,"accession":"0000902664-07-001053","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000902664-07-001053","line_url":"/filing/0000902664-07-001053#line-9","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL CORP; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8700.0,"shares_display":"8,700","price_per_share":8.72,"price_display":"8.72","price_state":"stated","total_value":75864.0,"total_display":"75,864.00","shares_owned_after":64876.0,"shares_owned_after_display":"64,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":8538337,"accession":"0000902664-07-001053","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000902664-07-001053","line_url":"/filing/0000902664-07-001053#line-8","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL CORP; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8368.0,"shares_display":"8,368","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":73220.0,"total_display":"73,220.00","shares_owned_after":38368.0,"shares_owned_after_display":"38,368","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":8538336,"accession":"0000902664-07-001053","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000902664-07-001053","line_url":"/filing/0000902664-07-001053#line-7","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Highbridge International LLC; HIGHBRIDGE CAPITAL CORP; HIGHBRIDGE CAPITAL MANAGEMENT LLC; Dubin Glenn; Highbridge Convertible Arbitrage Master Fund, L.P.; Swieca Henry","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4034.0,"shares_display":"4,034","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":35136.14,"total_display":"35,136.14","shares_owned_after":68910.0,"shares_owned_after_display":"68,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000727510","name":"ENZON PHARMACEUTICALS INC","url":"/issuer/0000727510","role":"Ten percent owner","n_filings":9,"first_seen":"2007-02-20","last_seen":"2007-08-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001308598","retrieved_at":"2026-08-21T18:29:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}